×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Interview with Dr Alain Cribier, MD

Since the beginning of TAVI, indications have shifted from compassionate to high risk patients. What are in 2011 the good candidates for TAVI ? It is true than over the last 9 years, the indications have been cautiously extended from companionate cases (I-REVIVE trial, RECAST trial) to high...

Scroll Up